Research and development

Fulton is a research and development company that operates and invests in the pharmaceutical industry in order to design and manufacture innovative finished products, medical devices and food supplements.

Fulton works in synergy with a network of highly qualified companies, businesses and organisations in technical and industrial development.

Fulton connects the ever-increasing demand for innovative new products with the stakeholders who can meet said demand. In this sense, Fulton  acts as a strategic partner, making its specific skills available to customers and investors, in order to direct and implement new projects and processes.

By working in diversified sectors and segments, Fulton has developed an accredited wealth of technical, scientific, commercial and marketing skills that enable it to satisfy the most demanding stakeholders in the creation of complex and challenging projects.

Fulton’s main activities include:

• Formulation
• Raw material research and assessment
• Quality and laboratory analyses
• Laboratory prototype development
• Stability studies
• Validation of analytical methods
• Pilot batches and industrialisation
• Scale-up and process validation equipment
• Investigational Medicinal Product (IMP) production

Fulton is able, in its Research & Development laboratories, to devise and prepare new formulations and products with a high technological level, based on innovativeness and capable of meeting the demand of a market that is constantly evolving and becoming increasingly aware and mature.

Fulton’s research and development department works to implement and patent new technologies all the time.

Fulton has developed and patent two new formulations:

• SUBLINGUAL TABLET CONTAINING SILDENAFIL CITRATE [link to the news]
• NITROFURANTOIN-BASED EXTENDED-RELEASE GASTRO-RESISTANT FORMULA (Pending) [link to the news]

Fulton has a strong track record in pharmaceutical manufacturing, operating in controlled environments and in departments equipped to enable efficiency and flexibility.

The main technologies applied in the production of proprietary medicinal products and medical devices:

• Manufacturing of suppositories and ovules with a fat or hydrophilic base, including those containing corticosteroids, lactic ferments or plant-based derivatives
• Powder mixing and dry granulation
• Hard gelatine capsules
• Simple tablets
• Breakdown of powders for oral or topical use in vials
• Secondary packaging
• Serialisation

All production activities are carried out with top quality certified machinery.

Medical devices and food supplements constantly need new functional ingredients and, above, all new technologies that maximize their efficacy, bioavailability and shelf-life.

Fulton, in synergy with highly specialised companies and laboratories, works to achieve these important goals.

The main technologies applied to medical devices and food supplements in distribution:

• NANOEMULSION DELIVERY SYSTEM (NeDS)
• SELF EMULSIFYING ANHYDROUS DISPERSION SYSTEM (SeADS)
• REW CAP VIALS
• LIPOMATRIX
• ENTEROSOMA
• ADSORBED NANOEMULSION SYSTEM (ANeS)